Advicenne S.A. reported sales results for the year 2022. For the period, the company reports sales of 3.7 million, up 13% compared to the previous year (2021: 3.3 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.794 EUR | -0.33% | +8.86% | -32.56% |
08/04 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
25/03 | Advicenne: ODD designation in cystinuria | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.56% | 23.73M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- ALDVI Stock
- News Advicenne
- Advicenne S.A. Reports Sales Results for the Year 2022